(Date:8/8/2008)...GO -- Parkinson,s disease and drug addiction are p...ine in the brain. Parkinson,s patients don,t have ...hough the importance of dopamine in these disorder... mystery. , New research from Northwestern Unive...hat dopamine strengthens and weakens the two prima...
(Date:8/8/2008)...pe was inserted through 1-inch cut behind uterus a...Aug. 8 (HealthDay News) -- In what they say may be...tes, surgeons at New York-Presbyterian Hospital/Co... gallbladder without making any external incisions...ng clinical research trial, involved insertion of ...
(Date:8/8/2008)...e Mercy Prenatal, Cervical Cancer Screening Partic...ift Card, PHILADELPHIA, Aug. 8 /PRNewswire/ -- Ke...stance care organization in Pennsylvania, in,conju... (DVCH), a,non-profit organization that provides c...oral health care services, celebrate National Heal...
(Date:8/8/2008)...s release is available in German . Many sports...city or country they are representing, not on a re...und that choosing the color red for a uniform in c...s split-second decision-making ability and even pr...gemann, Bernd Strauss and Jan Leibing from the Uni...
Breaking Medicine News(10 mins):Health News:Why dopamine freezes parkinson patients and drives drug addicts 2Health News:Why dopamine freezes parkinson patients and drives drug addicts 3Health News:New Technique Removes Gallbladder Without External Incisions 2Health News:Keystone Mercy and DVCH to Offer Screenings for National Health Center Week 2Health News:Red all over: how the color red affects a referee's judgment 2...-aged and older women without a history of stiff a...joints// flexible and muscles sturdy; it also keep... their 70s, who exercised 75 minutes a week report...rcised less, while women who spent as long as 2 1/...
...s of climate change in terms of unusual animal beh...migration//. However, scientists at the University...ndicator – the king penguin – to investigate wheth...ects of climate change. “If penguins are travell...
... have cancer or are at high risk of developing can...// appear? Research happening today at the Univer...is bringing us to that point. New genetic markers ... can identify early signs of cancer and predict wh...
...ing into the oncology segment starting with the la...investment of $3.4 million. The company has est...at its facility in Baddi, Himachal Pradesh (India)...boration with Blausiegel, a Brazilian company, for...
Other Medicine News:Health News:Can Science Stop Cancer Before It Starts? 2(Date:8/6/2008).... 6 /- GlaxoSmithKline (NYS...a from over 14,600 patients,in 54 clinical studies...,associated with the anti-HIV medication abacavir....analysis undertaken by the D:A:D cohort had found ...ghly active antiretroviral,therapy (HAART) regimen...
(Date:8/6/2008)..., Aug. 6 /- Terumo Heart, Inc. announ...M) Left Ventricular Assist,System (LVAS) took plac...ascular Center in Ann Arbor, Michigan. The surgery...onal Co-Principal Investigator for the,DuraHeart U...third,generation left ventricular assist system co...
(Date:8/5/2008)...ims to help heart failure patients survive until,t...blood damage than,earlier heart devices, ANN ARBO...y Shannon,made history on July 30. That,s when he ...ceive a new type of experimental and very high-tec...implanted in his chest, and,connected to his faili...
(Date:8/5/2008)...id in Bone Marrow Transplants, Blood Diseases--,...New research sheds,light on the biological events ...o the broad variety of cells that circulate in the...of bone marrow transplants and,develop better trea...we better understand the biological pathways that ...
Breaking Medicine Technology:Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy 2Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy 3Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy 4Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy 5First DuraHeart(TM) Left Ventricular Assist System Implanted in the U.S. Pivotal Trial 2First U.S. Patient to Receive New Heart-Assist Device Doing Well After Surgery at University of Michigan 2First U.S. Patient to Receive New Heart-Assist Device Doing Well After Surgery at University of Michigan 3First U.S. Patient to Receive New Heart-Assist Device Doing Well After Surgery at University of Michigan 4Protein Key to Control Growth of Blood Cells 2Protein Key to Control Growth of Blood Cells 3Signalife Appoints Lee Ehrlichman as Company Director and Operations Director 3B Additional Notice Received From Amex Regarding Sharholders Equity Def 5458 1Signalife Appoints Lee Ehrlichman as Company Director and Operations Director 3B Additional Notice Received From Amex Regarding Sharholders Equity Def 5458 2Signalife Appoints Lee Ehrlichman as Company Director and Operations Director 3B Additional Notice Received From Amex Regarding Sharholders Equity Def 5458 3Signalife Appoints Lee Ehrlichman as Company Director and Operations Director 3B Additional Notice Received From Amex Regarding Sharholders Equity Def 5458 4Schering Plough Highlights PEGINTRON 28TM 29 and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week 28DDW 29 Annual Meeting 2084 1Schering Plough Highlights PEGINTRON 28TM 29 and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week 28DDW 29 Annual Meeting 2084 2Schering Plough Highlights PEGINTRON 28TM 29 and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week 28DDW 29 Annual Meeting 2084 3Schering Plough Highlights PEGINTRON 28TM 29 and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week 28DDW 29 Annual Meeting 2084 4Schering Plough Highlights PEGINTRON 28TM 29 and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week 28DDW 29 Annual Meeting 2084 5Schering Plough Highlights PEGINTRON 28TM 29 and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week 28DDW 29 Annual Meeting 2084 6Schering Plough Highlights PEGINTRON 28TM 29 and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week 28DDW 29 Annual Meeting 2084 7Simple model cell is key to understanding cell complexity 3334 1Simple model cell is key to understanding cell complexity 3334 2TruFUSE 28R 29 Minimally Invasive Facet Fusion Procedure Tops 3 000 Spinal Levels 19530 1TruFUSE 28R 29 Minimally Invasive Facet Fusion Procedure Tops 3 000 Spinal Levels 19530 2...07 - ERBITUX (cetuximab), the,first approved IgG1 ... factor receptor (EGFR) developed and commercializ...of nine oral and 46,poster presentations at the re...an Society of Clinical Oncology (ASCO)., This year...ive,clinical development of ERBITUX reporting Phas...
... Tested in Patients Reduces,Severity of Adult Leuk...a, the Danish,biopharmaceutical company, announced...ist of Bcl-2, has shown early evidence of,efficacy...c,Lymphocytic Leukaemia (CLL). The results of the ...eeting of the American Society of,Clinical Oncolog...
Other Medicine Technology:Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 2Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 3Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 4Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 5Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 6Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 7Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 8Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 9Extensive Clinical Data on Erbitux Presented at the 2007 ASCO,Annual Meeting 10Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 2Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 3Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 4Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 5Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 6Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 7Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 8Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 9...e a highly effective adjunct in surgical repair. C...fibrinogen and thrombin, TISSEEL VH Fibrin Sealant...ade to produce a biocompatible fibrin matrix clot ...tural plasma clot and stops bleeding quickly and r...
The Icy catheter is inserted into the femoral vein and resides in the inferior vena cava. Saline flow within the balloons creates a proprietary vortex flow pattern which maximizes heat exchange with
PeriVac Pericardiocentesis Kit with 8.3F straight catheter
Designed to minimize emblolic debris in SVGs and carotids
Medicine Products: